Movement Alert|Chewy, Inc. Falls 6.1% in Regular Trading, Q2 Revenue Misses Estimates Amid Growth Concerns

Market Focus
Yesterday

On September 9, Chewy, Inc. fell 6.1% in regular trading, trading at $21.45/share, with turnover of $31.18 million. The decline was triggered by the company's fiscal Q2 earnings report, where revenue fell short of some analyst expectations.

Chewy reported fiscal Q2 adjusted earnings of $0.36 per diluted share, up 9.1% year-over-year, in line with consensus. However, net sales of $3.33 billion, while up 7.4% year-over-year, missed certain institutional estimates of $3.361 billion. The revenue shortfall comes against the backdrop of Chewy having already lowered its full-year sales guidance to $13.40-$13.55 billion from $13.60-$13.75 billion following Q1 results, citing a tougher consumer environment and softer pet category demand.

Analysts had flagged Q2 as a key test for management's second-half outlook credibility. The modest revenue miss failed to ease investor concerns about growth momentum, particularly as weaker premiumization trends and cautious consumer spending have constrained the pet-care category. Options markets had priced in an implied swing of 16.37%, and the current decline remains within that expected range. The analyst consensus maintains an average overweight rating with a mean price target of $31.09.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10